• Monoclonal antibody treatment for malaria shows encouraging results

    15 days ago - By STAT

    An experimental antibody treatment prevented malaria in the majority of participants in a small but important new study , providing a measure of hope in the effort to lower the burden of the disease worldwide.
    Only two of 17 participants in the Phase 1 clinical trial contracted malaria after being given the monoclonal antibody treatment, known as L9LS, according to results of the trial, which were published Wednesday in the New England Journal of Medicine.
    Read more ...